- The FDA cleared Lumipulse, a blood test by Fujirebio Diagnostics, which detects amyloid beta plaques – a key Alzheimer’s marker – by measuring proteins p-Tau217 and beta-amyloid 1-42. This offers a faster, cheaper and more accessible alternative to PET scans or spinal taps.
- Current methods (PET scans and spinal taps) are costly and invasive, often delaying diagnosis. Lumipulse’s simple blood draw could make early detection feasible for millions, especially as Alzheimer’s cases are projected to double by 2050.
- Clinical trials showed 91.7 percent accuracy in aligning with positive PET/spinal tap results and 97.3 percent accuracy in ruling out amyloid buildup. However, false positives/negatives remain possible, requiring supplemental clinical evaluation.
- Early detection could help identify candidates for new drugs like Leqembi and Kisunla, though these treatments face skepticism due to high costs, limited efficacy, and serious side effects.
- While Lumipulse marks progress, debates persist about amyloid’s role in Alzheimer’s and the need for better therapies. Competing blood tests are in development, signaling a shift toward more accessible diagnostics – but clearer guidelines and more effective treatments are still needed.
(Natural News)—For decades, diagnosing Alzheimer’s disease has been an expensive, invasive and often inaccessible process. But a blood test approved the Food and Drug Administration (FDA) changes that.
On May 16, the FDA cleared the first-ever blood test designed to detect signs of Alzheimer’s. Developed by Fujirebio Diagnostics, the test – branded as Lumipulse – measures two key proteins in the blood to identify amyloid beta plaques, a hallmark of the neurodegenerative disease.
The Lumipulse test measures the ratio of two proteins, p-Tau217 and beta-amyloid 1-42, in the blood. Research has shown that an imbalance in these proteins correlates with the presence of amyloid plaques in the brain, a key indicator of Alzheimer’s.
While the test does not directly measure amyloid, its accuracy is striking. Clinical trials showed that 91.7 percent of positive results aligned with PET scan or spinal tap confirmations, while 97.3 percent of negative results correctly ruled out amyloid buildup.
Prior to Lumipulse’s approval, confirming the disease required costly PET scans (often not covered by insurance) or invasive spinal taps to analyze cerebrospinal fluid. These barriers delayed diagnoses, leaving patients in limbo while their cognitive health deteriorated.
The Lumipulse test, requiring only a simple blood draw, eliminates many of these obstacles. It offers a more practical solution for primary care physicians and specialists alike, marking a pivotal moment in the fight against the devastating neurodegenerative disease.
This breakthrough could revolutionize early detection – making diagnosis faster, cheaper, and more widely available for millions of Americans. Alzheimer’s disease affects more than six million Americans, a number projected to double by 2050. (Related: Iridology proven to have scientific basis? Retinal scan could become early detection system for Alzheimer’s disease.)
A simpler Alzheimer’s test is here – but is it reliable?
Early detection is crucial, especially with the recent approval of drugs like Leqembi (from Biogen and Eisai) and Kisunla (from Eli Lilly) that aim to slow Alzheimer’s progression. However, these treatments have faced skepticism due to high costs and limited efficacy. Serious side effects, including brain swelling and bleeding, have also been highlighted.
A simpler diagnostic tool could expand access to these therapies by identifying candidates earlier in the disease’s progression – when interventions may be most effective. Despite the optimism, experts caution that the test is not foolproof.
False positives and negatives remain a risk, and the FDA stresses that results must be interpreted alongside other clinical evaluations. Additionally, while the test is a major step forward, it does not replace comprehensive neurological assessments.
The approval of Lumipulse signals a shift toward more accessible, less invasive diagnostics – but the battle against Alzheimer’s is far from over. Researchers still debate the role of amyloid plaques in the disease, and the effectiveness of anti-amyloid drugs remains controversial. Meanwhile, companies like C2N Diagnostics and Quanterix are racing to develop competing blood tests, promising even greater accuracy and affordability in the years ahead.
Watch this video about preventing dementia and Alzheimer’s the natural way.
More related stories:
- Cinnamon beats Alzheimers.
- Five things you can do to guard against Alzheimers.
- Obesity causes Alzheimers; massive wave of Alzheimer’s to strike America in the years ahead.
- Dr. Michael Nehls proposes Unified Theory of Alzheimer’s Disease (UTAD) to prevent, cure dementia.
Sources include:
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.